Purple Biotech PPBT
NASDAQ PPBT
$1.46 -0.06 (-3.90%)
As of: Oct 2, 2026 · 2:53 PM EDT

Purple Biotech (PPBT) Selling, General & Administrative (2014 - 2026)

Updated

Purple Biotech's Selling, General & Administrative was $597,000 in Q2 2026, down 12.6% from $683,000 a year earlier and down 41.5% from the prior quarter.

Analysis

Purple Biotech (PPBT) Selling, General & Administrative (2014 - 2026) Analysis & Trends

On a trailing twelve-month basis, Purple Biotech's Selling, General & Administrative was $3.53 million through Jun 30, 2026, up 32.2% year-over-year; for FY2025, it came in at $3.25 million, up 1.9% from FY2024.

  • Selling, General & Administrative shows a five-year compound annual growth rate of -11.6% (FY2020 to FY2025).
  • In earlier years, Selling, General & Administrative was $3.18 million in FY2024 (-39.2%), $5.24 million in FY2023 (-16.6%), $6.28 million in FY2022 (+2.9%) and $6.11 million in FY2021 (+1.8%).
  • The Q2 2026 figure marks the lowest quarterly Selling, General & Administrative since Q4 2024.
  • Compared with a year earlier, Selling, General & Administrative was higher in two of the last eight quarters, with growth averaging 1.4%.
  • The best year-over-year quarter for Selling, General & Administrative over five years was Q4 2025 (growth of 103.4%); the worst was Q4 2024 (a decline of 45.6%).
  • Per Business Quant data, PPBT's Selling, General & Administrative in the three quarters before Q2 2026 was $1.02 million (Q1 2026), $1.14 million (Q4 2025) and $780,000 (Q3 2025).
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) SG&A (Qtr)
1 Johnson & Johnson 638.12 Bn 556.64 Bn 17.26 Bn 6.43 Bn
2 AbbVie 462.60 Bn 435.75 Bn 12.70 Bn 3.63 Bn
3 Merck 358.70 Bn 313.13 Bn 12.21 Bn 2.90 Bn
4 Novartis Ag 272.16 Bn 228.03 Bn 11.24 Bn -3.24 Bn
5 Astrazeneca 250.36 Bn 223.92 Bn 12.86 Bn -5.65 Bn
6 Amgen 227.87 Bn 183.27 Bn 7.24 Bn 1.75 Bn
7 Gilead Sciences 184.97 Bn 159.08 Bn 6.22 Bn 1.92 Bn
8 Pfizer 162.61 Bn 109.56 Bn 10.94 Bn 3.41 Bn
9 Vertex Pharmaceuticals 132.45 Bn 104.46 Bn 2.84 Bn 582.20 Mn
10 Purple Biotech 249,214.64 191,214.64 - 597,000.00
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 597,000.00
Mar 31, 2026 1.02 Mn
Dec 31, 2025 1.14 Mn
Sep 30, 2025 780,000.00
Jun 30, 2025 683,000.00
Mar 31, 2025 646,000.00
Dec 31, 2024 558,000.00
Sep 30, 2024 785,000.00
Jun 30, 2024 865,000.00
Mar 31, 2024 1.04 Mn
Dec 31, 2023 1.03 Mn
Sep 30, 2023 1.16 Mn
Jun 30, 2023 1.43 Mn
Mar 31, 2023 1.62 Mn
Dec 31, 2022 1.78 Mn
Sep 30, 2022 1.62 Mn
Jun 30, 2022 1.51 Mn
Mar 31, 2022 1.38 Mn
Dec 31, 2021 1.49 Mn
Sep 30, 2021 1.42 Mn
API Access

Purple Biotech Selling, General & Administrative API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=selling-general-and-administrative&ticker=PPBT&period=max&api_key=YOUR_API_KEY